Preoperative Oral Carbohydrate Improved Postoperative Insulin Resistance in Rats through the PI3K/AKT/mTOR Pathway

被引:4
|
作者
Wang, Zhiguo [1 ]
Liu, Yiqing [2 ]
Li, Qi [1 ]
Ruan, Canping [1 ]
Wu, Bin [3 ]
Wang, Qiang [4 ]
Hu, Zhiqian [1 ]
Qin, Huanlong [5 ]
机构
[1] Second Mil Med Univ, Dept Gen Surg, Shanghai Chang Zheng Hosp, Shanghai, Peoples R China
[2] Second Mil Med Univ, Lib, Shanghai, Peoples R China
[3] Second Mil Med Univ, Dept Thorac Surg, Shanghai Chang Zheng Hosp, Shanghai, Peoples R China
[4] Shanghai Zhabei Cent Hosp, Dept Gen Surg, Shanghai, Peoples R China
[5] Tongji Univ, Dept Gen Surg, Peoples Hosp 10, Shanghai 200092, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2015年 / 21卷
基金
中国国家自然科学基金;
关键词
Leucine; Insulin Resistance; Perioperative; Phosphoinositide Phospholipase C; TOR Serine-Threonine Kinases; RANDOMIZED CLINICAL-TRIAL; MAMMALIAN PROTEIN; GLUCOSE-POLYMER; LEUCINE; METABOLISM; LIVER;
D O I
10.12659/MSM.891063
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Preoperative oral carbohydrate (OCH) improves postoperative insulin resistance (PIR) and insulin sensitivity. However, the exact mechanisms involved in the improvement of PIR with respect to preoperative OCH are still not clear. The aim of this study was to investigate the involvement of preoperative OCH and PI3K/AKT/mTOR pathway in reducing PIR in rats. Material/Methods: Forty male Sprague-Dawley rats were randomly assigned to PreOp, glucose, saline, and fasting groups. Rats in the PreOp, glucose, and saline groups received OCH, 5% glucose solution, and saline, respectively. Rats in the fasting group did not receive anything but were fasted 3 h before surgery. Blood glucose, insulin and leucine levels, and insulin resistance, secretion, and sensitivity indexes were measured before and after surgery. mRNA and protein (total and phosphorylated) levels of mTOR, IRS-1, PI3K, PKB/AKT, and GlUT4 were measured using real-time polymerase chain reaction and Western blot in skeletal muscles. Results: In the PIR experiment, blood glucose, serum insulin, insulin resistance, and serum leucine levels were all significantly lower in the PreOp group than in the other 3 groups (P<0.05) after surgery. HOMA-ISI were higher in the PreOp group vs the other 3 groups after surgery (P<0.05), and HOMA-b in the PreOp group was higher than that in the other 3 groups at 30 and 120 min after surgery. Additionally, post-operative phosphorylated IRS-1, PI3K, and AKT protein levels were significantly higher in the PreOp group than in the other 3 groups (P<0.05), but no significant differences were observed in their respective protein levels (P>0.05). Conclusions: OCH decreases postoperative insulin resistance and improves postoperative insulin sensitivity in skeletal muscles through the PI3K/AKT/mTOR pathway.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 50 条
  • [21] Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
    Westin, Jason R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 335 - 342
  • [22] Evaluation of the PI3K/AKT/mTOR pathway in multiple sclerosis
    Mammana, Santa
    Fagone, Paolo
    Cavalli, Eugenio
    Basile, Maria Sofia
    Petralia, Maria Cristina
    Nicoletti, Ferdinando
    Mangano, Katia
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S51 - S51
  • [23] Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
    Markman, Ben
    Dienstmann, Rodrigo
    Tabernero, Josep
    ONCOTARGET, 2010, 1 (07) : 530 - 543
  • [24] Stability Analysis of the PI3K–Akt–mTOR Signaling Pathway
    Sapega T.S.
    Guria G.T.
    Biophysics, 2020, 65 (2) : 259 - 267
  • [25] The pathway of PI3K/AKT/mTOR in pulmonary carcinoids.
    Zhang, Zixuan
    Wang, Mengzhao
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
    Dong, Chao
    Wu, Jiao
    Chen, Yin
    Nie, Jianyun
    Chen, Ceshi
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [27] The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma
    Fulda, S.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (06) : 729 - 737
  • [28] Effect of PI3K/Akt/mTOR signaling pathway on JNK3 in Parkinsonian rats
    Chen, Ying
    Zheng, Xiaozhen
    Wang, Ying
    Song, Junjie
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) : 1771 - 1775
  • [29] Targeting the mTOR/AKT/PI3K pathway in paediatric malignancies
    Pearson, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S74 - S74
  • [30] AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
    Bhatt, Aadra P.
    Damania, Blossom
    FRONTIERS IN IMMUNOLOGY, 2013, 3